Objective To study abnormalities in the resting ECG as independent predictors for all cause, cardiovascular disease (CVD), and coronary heart disease (CHD) mortality in a population based random ...

Correspondence to Dr Sarah Hudson, Bristol Heart Institute, University Hospitals Bristol NHS Foundation Trust, Bristol, BS2 8HW, UK; sarahhudsonuk{at}gmail.com Left ventricular ejection fraction (LVEF ...

Cardiovascular Research Group, Division of Clinical Sciences (Northern General Hospital), University of Sheffield, Sheffield, UK Correspondence to: Dr Julian Gunn, Cardiovascular Research Group, ...

Stroke, one of the most severe complications of atrial fibrillation (AF), can be prevented by oral anticoagulants in patients ...

1 Division of Cardiovascular Epidemiology, Institute of Environmental Medicine, IMM, Karolinska Institutet, Stockholm, Sweden 2 Division of Biostatistics, Institute of Environmental Medicine, IMM, ...

1 National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical ...

Objectives The use of cerebral embolic protection (CEP) during transcatheter aortic valve implantation (TAVI) has been studied in several randomised trials. We aimed to perform a systematic review and ...

Christian Stumpf, MD, Dept of Cardiology, University of Erlangen-Nuremberg, Ulmenweg 18, 91054 Erlangen, Germany; ch.stumpf{at}web.de Background: Increasing scientific data suggest a role for ...

Objective: To study the role of echocardiography in the stepwise evaluation of syncope. Design: A prospective observational study with an 18 month follow up. Setting: University teaching hospital ...

1 Imperial College, National Heart & Lung Institute, Royal Brompton Hospital, London, UK 2 Imperial College, National Heart & Lung Institute, Hammersmith Hospital, London, UK Correspondence to: Dr ...

Division of Cardiovascular Medicine, Addenbrooke’s Centre for Clinical Investigation, University of Cambridge, Cambridge, UK Correspondence to: Dr T Littlewood University of Cambridge, ACCI, Level 6 ...

Introduction The cardiac manifestations of Fabry disease are the leading cause of death, but risk stratification remains inadequate. Identifying patients who are at risk of adverse cardiac outcome may ...